"An Australian biotech startup with an office in Cambridge's Kendall Square has developed a way to deliver vaccines to patients without using a syringe or nasal mist. Vaxxas Inc. has developed the Nanopatch, which consists of thousands of vaccine-coated microprojections that penetrate the outer layers of a patient’s skin.
The nano-level sized microprojections are coated with vaccine and then released directly to key immune cells found just below the skin’s surface, according to Vaxxas CEO David Hoey."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
Posts
No comments:
Post a Comment